Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

Clinical trial NCT05189054 · RECRUITING

Trial details

NCT number: NCT05189054
Sponsor: Peking University Third Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Stereotactic Body Radiation Therapy Irradiation; Reaction Thoracic Tumor Recurrent Cancer

Start date: 2022-05-01
Primary completion: 2025-04-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.